前沿论文｜CELL INTELLIGENCE

Overcoming Therapy Resistance in Ovarian Cancer: From Molecular Mechanisms to Emerging Therapeutic Strategies.

PubMed 2026/08/14 发表Cancers (Basel)Q2 · IF 4.8（JCR 2025）

Engineering NK and T cells with metabolite-sensing receptors to target solid tumors.

PubMed 2026/03/23 发表Nat ImmunolQ1 · IF 26.5（JCR 2025）

Imaging CRISPR-edited CAR-T cell therapies with optical and positron emission tomography reporters.

PubMed 2026/01/01 发表TheranosticsQ1 · IF 14.9（JCR 2025）

CRISPR-Edited Cell Lines: A New Era in Functional Oncology Research.

PubMed 2026/01/01 发表Curr Pharm DesQ2 · IF 3.2（JCR 2025）

Current Developments of CAR-T and CAR-NK Cell Therapies for Ovarian Cancer.

PubMed 2025/12/27 发表Stem Cell Rev RepQ2 · IF 4.9（JCR 2025）

Autophagy disruption primes CAR-T cell metabolism for sustained rejection of ovarian tumors.

PubMed 2025/10/10 发表bioRxiv

Novel applications of gene and cell therapies in the treatment of gynecological disorders.

PubMed 2025/10/08 发表Front Med (Lausanne)Q1 · IF 3.6（JCR 2025）

Allogeneic NKG2D CAR-T Cell Therapy: A Promising Approach for Treating Solid Tumors.

PubMed 2025/09/22 发表BiomedicinesQ2 · IF 4.5（JCR 2025）

Mitigating T cell DNA damage during PARP inhibitor treatment enhances antitumor efficacy.

PubMed 2025/05/07 发表Sci Transl MedQ1 · IF 15.6（JCR 2025）

CRISPR-Cas9 knockout of DGKα/ζ improves the anti-tumor activities of TAG-72 CAR-T cells in ovarian cancer.

PubMed 2025/03/05 发表Mol Ther OncolQ1 · IF 8.5（JCR 2025）

前沿论文 12